[Thymoleptic effect of a new dibenzodiazepine derivative].
D000275:Adjustment Disorders / Q000188:drug therapy; D000328:Adult; D001714:Bipolar Disorder / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D003984:Dibenzazepines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003875:Drug Eruptions; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000697:Central Nervous System Stimulants; D003984:Dibenzazepines; D014149:Tranquilizing Agents
Thymoleptische Wirkung eines neuen Dibenzodiazepin-Derivates.